Intensity Therapeutics, Inc. (INTS)
USD 1.91
(-4.5%)
USD 1.91
(-4.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 147 Thousand | 179.03 Thousand | - | - | - |
| Gross Profit | -147 Thousand | -179.03 Thousand | - | - | - |
| Operating Expenses | 8.31 Million | 7.55 Million | 8.01 Million | 6.22 Million | 5.67 Million |
| Selling, General and Administrative Expenses | 3.38 Million | 2.41 Million | 2.15 Million | 1.17 Million | 1.23 Million |
| Research and Development Expenses | 4.78 Million | 5.13 Million | 5.85 Million | 5.05 Million | 4.43 Million |
| Other Expenses | - | 47.64 Thousand | 115.51 Thousand | 118.75 Thousand | 144.98 Thousand |
| Cost and Expenses | 8.31 Million | 7.55 Million | 8.01 Million | 6.22 Million | 5.67 Million |
| Operating Income | -8.31 Million | -7.63 Million | -8.01 Million | -6.22 Million | -5.67 Million |
| Interest Expense | 305 Thousand | 81.78 Thousand | 16.76 Thousand | - | - |
| Income Tax Expense | - | -131.9 Thousand | -2609.00 | -74 Thousand | -150.7 Thousand |
| Earnings before Tax | -10.53 Million | -7.58 Million | -7.89 Million | -6.03 Million | -5.37 Million |
| Net Income | -10.53 Million | -7.45 Million | -7.89 Million | -5.95 Million | -5.22 Million |
| Earnings Per Share Basic | -1.38 | -0.57 | -0.60 | -0.45 | -0.40 |
| Earnings Per Share Diluted | -1.38 | -0.57 | -0.60 | -0.45 | -0.40 |
| Weighted Average Shares Outstanding | 8.61 Million | 13.09 Million | 13.09 Million | 13.09 Million | 13.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.61 Million | 13.09 Million | 13.09 Million | 13.09 Million | 13.09 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -10.08 Million | -7.4 Million | -7.87 Million | -6.03 Million | -5.37 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 282.21 Thousand | - | - | - |
| Cost of Revenue | 6000.00 | 6000.00 | 5892.00 | 147 Thousand | 2019.00 | 38.61 Thousand |
| Gross Profit | -6000.00 | -6000.00 | 276.32 Thousand | -147 Thousand | -2019.00 | -38.61 Thousand |
| Operating Expenses | 5.06 Million | 4.73 Million | 3.34 Million | 8.17 Million | 2.49 Million | 1.22 Million |
| Selling, General and Administrative Expenses | 1.5 Million | 1.92 Million | 1.54 Million | - | 1.13 Million | 362.49 Thousand |
| Research and Development Expenses | 3.56 Million | 2.81 Million | 1.8 Million | - | 1.35 Million | 859.21 Thousand |
| Other Expenses | - | - | 5696.00 | - | 13.23 Thousand | 4349.00 |
| Cost and Expenses | 5.06 Million | 4.74 Million | 3.35 Million | 8.31 Million | 2.49 Million | 1.22 Million |
| Operating Income | -5.06 Million | -4.74 Million | -3.35 Million | -8.31 Million | -2.49 Million | -1.22 Million |
| Interest Expense | - | - | -161.00 | 305 Thousand | - | 221.77 Thousand |
| Income Tax Expense | - | -37.27 Thousand | -2.00 | 1.00 | -147.53 Thousand | 221.6 Thousand |
| Earnings before Tax | -4.97 Million | -4.6 Million | -3.17 Million | -10.53 Million | -2.32 Million | -3.7 Million |
| Net Income | -4.97 Million | -4.6 Million | -3.17 Million | -10.53 Million | -2.32 Million | -3.7 Million |
| Earnings Per Share Basic | -0.36 | -0.34 | -0.23 | - | -0.17 | -0.28 |
| Earnings Per Share Diluted | -0.36 | -0.34 | -0.23 | - | -0.17 | -0.28 |
| Weighted Average Shares Outstanding | 13.71 Million | 13.7 Million | 13.7 Million | 8.61 Million | 13.7 Million | 13.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.71 Million | 13.7 Million | 13.7 Million | 8.61 Million | 13.7 Million | 13.09 Million |
| Gross Margin | - | - | 0.98 | - | - | - |
| EBIT Margin | - | - | -11.86 | - | - | - |
| Profit Margin | - | - | -11.24 | - | - | - |
| EBITDA | -5.06 Million | -4.73 Million | -3.34 Million | - | -2.32 Million | -1.21 Million |
| Earnings Before Tax Margin | - | - | -11.88 | - | - | - |
LUXFF
MASFIN
600375
0QKP
BTC
6558